In summary, our immunostaining experiments provide evidence that AIM2 and IFI16 bind NETs in the setting of diffuse proliferative lupus nephritis, establishing AIM2 and IFI16 as NET-bound SLE autoantigens. The gene discussed is AIM2; the disease is systemic lupus erythematosus.